New logo with tagline.jpg
VAX-24 Phase 1/2 Adult Proof-of-Concept Data Published in The Lancet Infectious Diseases Highlight Best-in-Class Potential of Vaxcyte’s 24-Valent Pneumococcal Conjugate Vaccine (PCV) Candidate
December 04, 2023 18:35 ET | Vaxcyte, Inc.
-- In the Study, VAX-24 Demonstrated a Safety and Tolerability Profile Similar to Prevnar 20® (PCV20) at all Doses Studied -- -- All 24 Serotypes of VAX-24 at Conventional 2.2 mcg PCV Dose Met or...
Eledon Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
December 04, 2023 18:00 ET | Eledon Pharmaceuticals, Inc.
Eledon Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Atour Lifestyle Holdings Limited Announces Proposed Registered Secondary Offering of American Depositary Shares by Legend Capital
December 04, 2023 17:35 ET | Atour Lifestyle Holdings Limited
SHANGHAI, China, Dec. 04, 2023 (GLOBE NEWSWIRE) -- Atour Lifestyle Holdings Limited (“Atour” or the “Company”) (NASDAQ: ATAT), a leading hospitality and lifestyle company in China, today announced...
LeddarTech et Prospector Capital Corp. annoncent l’entrée en vigueur de la déclaration d’enregistrement et la tenue d’une assemblée générale extraordinaire le 13 décembre 2023 visant l’approbation du regroupement d’entreprises
December 04, 2023 17:30 ET | LeddarTech inc.
QUÉBEC, 04 déc. 2023 (GLOBE NEWSWIRE) -- LeddarTech Inc.® (« LeddarTech » ou l’« Entreprise »), une société de logiciels automobiles qui fournit des technologies logicielles de fusion bas...
Sprott Focus Trust, Inc. (Nasdaq-FUND) Declares Fourth Quarter Common Stock Distribution of $0.1270 Per Share
December 04, 2023 17:11 ET | Sprott Focus Trust, Inc.
TORONTO, Dec. 04, 2023 (GLOBE NEWSWIRE) -- Sprott Focus Trust, Inc. (Nasdaq-FUND) (the “Fund” or “FUND”) has declared a quarterly distribution of $0.1270 per share on its Common Stock. The...
NeuroPace Logo.png
NeuroPace to Leverage the Power of its RNS System’s Novel Data Collection, Brain Monitoring and Analysis Capabilities in Groundbreaking Collaboration
December 04, 2023 17:07 ET | NeuroPace, Inc.
First of its kind, multi-year collaboration leverages RNS System’s data to track responses of implanted RNS System patients enrolled in a biotechnology company’s clinical trial In strategic data...
Kernel Group Holdings, Inc. Confirms Funding to Extend Period to Consummate Initial Business Combination
December 04, 2023 16:59 ET | Kernel Group Holdings, Inc
New York, Dec. 04, 2023 (GLOBE NEWSWIRE) -- Kernel Group Holdings, Inc. (NASDAQ: KRNLU, KRNL, KRNLW) (“KRNL” or the “Company”), a special purpose acquisition company, announced today it caused to be...
PDS Biotech Logo.png
PDS Biotechnology Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
December 04, 2023 16:50 ET | PDS Biotechnology Corporation
PRINCETON, N.J., Dec. 04, 2023 (GLOBE NEWSWIRE) -- PDS Biotechnology Corporation (Nasdaq: PDSB) (“PDS Biotech” or “Company”), a clinical-stage immunotherapy company developing a growing pipeline of...
Jupiter Acquisition Corporation Announces Intent to Convene and Adjourn its Special Meeting of Stockholders to December 12, 2023
December 04, 2023 16:45 ET | Jupiter Acquisition Corporation
Hobe Sound, FL, Dec. 04, 2023 (GLOBE NEWSWIRE) -- Jupiter Acquisition Corporation (NASDAQ:JAQC) (“Jupiter”) today announced that it intends to convene and then adjourn, without conducting any...